| Year |
Citation |
Score |
| 2020 |
Luginbuhl A, Johnson JM, Harshyne L, Tuluc M, Gargano S, Leiby B, Curry JM, Cognetti DM, Axelrod RS, Bhateja P, Old MO, Rodeck U, Argiris A. Window-of-opportunity trial of nivolumab with or without the IDO inhibitor BMS-986205 in patients with resectable squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology. 38: TPS6595-TPS6595. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps6595 |
0.309 |
|
| 2019 |
Sokol K, Rhoades R, Leiby BE, Binder A, Chapman AE, Porcu P, Flomenberg N, Grosso D, Palmisiano ND. Comprehensive geriatric assessment prior to autologous stem cell transplant as a predictor of patient outcomes: A retrospective review. Journal of Clinical Oncology. 37: e23023-e23023. DOI: 10.1200/Jco.2019.37.15_Suppl.E23023 |
0.303 |
|
| 2019 |
Luginbuhl A, Johnson J, Harshyne L, Tuluc M, Mardekian S, Leiby B, Curry J, Cognetti D, Kim Y, Mannion K, Rodeck U, Argiris A. A window of opportunity trial of preoperative nivolumab with or without tadalafil in squamous cell carcinoma of the head and neck (SCCHN): Safety, clinical, and correlative outcomes Annals of Oncology. 30: v453. DOI: 10.1093/Annonc/Mdz252.008 |
0.319 |
|
| 2018 |
Godwin JL, Hoffman-Censits JH, Den RB, Knudsen KE, Schiewer MJ, Leiby BE, Southwell T, Hubert C, Patnaik A, Sonpavde G, Sartor AO, Yang ES, Kelly WK. c15-162: Phase IB trial of radium 223 and niraparib in patients with castrate resistant prostate cancer (NiraRad). Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.6_Suppl.Tps385 |
0.308 |
|
| 2018 |
McNair C, Xu K, Mandigo AC, Benelli M, Leiby B, Rodrigues D, Lindberg J, Gronberg H, Laere BD, Dirix L, Visakorpi T, Li F, Feng FY, Bono Jd, Demichelis F, et al. Abstract IA03: Differential impact of RB pathway status on E2F1 reprogramming and disease progression in human prostate cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-Ia03 |
0.301 |
|
| 2017 |
Williams NL, Nowak-Choi K, Skowronski J, Dan T, Eldredge HB, Hoffman-Censits JH, Lin J, Kelly WK, Gomella LG, Lallas CD, Trabulsi EJ, Hurwitz M, Dicker A, Leiby BE, Dabbish N, et al. Evaluating the effect of therapy duration on survival in patients with metastatic castration-resistant prostate cancer receiving radium-223. Journal of Clinical Oncology. 35: e593-e593. DOI: 10.1200/Jco.2017.35.6_Suppl.E593 |
0.32 |
|
| 2016 |
Tatarian T, Jiang W, Leiby BE, Grigoli A, Jimbo M, Dabbish N, Neoptolemos JP, Greenhalf W, Costello E, Ghaneh P, Halloran C, Palmer D, Buchler M, Yeo CJ, Winter JM, et al. Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial. Annals of Surgery. PMID 27893535 DOI: 10.1097/Sla.0000000000002088 |
0.301 |
|
| 2016 |
Lin J, Sama AR, Hoffman-Censits JH, Kennedy B, Kilpatrick D, Ye Z, Yang H, Mu Z, Leiby BE, Lewis N, Cristofanilli M, Kelly WK. A phase I/II study of the investigational drug alisertib in combination with abiraterone and prednisone (AP) for patients with metastatic castration-resistant prostate cancer (mCRPC) progressing on abiraterone. Journal of Clinical Oncology. 34: 311-311. DOI: 10.1200/Jco.2016.34.2_Suppl.311 |
0.314 |
|
| 2014 |
Leiby BE, Ten Have TR, Lynch KG, Sammel MD. Bayesian multivariate growth curve latent class models for mixed outcomes. Statistics in Medicine. 33: 3434-52. PMID 22961883 DOI: 10.1002/Sim.5596 |
0.456 |
|
| 2013 |
Mirtti T, Leiby BE, Abdulghani J, Aaltonen E, Pavela M, Mamtani A, Alanen K, Egevad L, Granfors T, Josefsson A, Stattin P, Bergh A, Nevalainen MT. Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy. Human Pathology. 44: 310-9. PMID 23026195 DOI: 10.1016/J.Humpath.2012.06.001 |
0.31 |
|
| 2012 |
Mirtti T, Leiby BE, Stattin P, Bergh A, Nevalainen MT, Abdulghani J, Pavela M, Aaltonen E, Mamtani A, Alanen KA, Egevad L, Granfors T, Josefsson A. Abstract C41: Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy. Cancer Research. 72: C41-C41. DOI: 10.1158/1538-7445.Prca2012-C41 |
0.31 |
|
| 2011 |
Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Tasman WS. Improving function in age-related macular degeneration: design and methods of a randomized clinical trial. Contemporary Clinical Trials. 32: 196-203. PMID 20974293 DOI: 10.1016/J.Cct.2010.10.008 |
0.301 |
|
| 2009 |
Leiby BE, Sammel MD, Ten Have TR, Lynch KG. Identification of Multivariate Responders/Non-Responders Using Bayesian Growth Curve Latent Class Models. Journal of the Royal Statistical Society. Series C, Applied Statistics. 58: 505-524. PMID 21637724 DOI: 10.1111/J.1467-9876.2009.00663.X |
0.432 |
|
| Show low-probability matches. |